Laboratory Denial Management Services

Recover Lost Revenue and Stop 2026 Payer Auto-Denials

In 2026, payers like UnitedHealthcare and Optum are not using manual reviewers to deny your claims. They are using AI algorithms trained to spot a single missing Z-Code or a mismatched LOINC code in milliseconds. If you are fighting these algorithms with spreadsheets and phone calls, you have already lost. Dastify Solutions is the laboratory denial management service that fights AI with AI. We do not wait for the rejection letter. We use predictive risk scoring to audit your claims against millions of payer rules before they leave your LIS.

Our "Shift-Left" Prevention Strategy

Most billing companies focus on fixing denials. We focus on preventing them. This is what we call “Shift-Left” Denial Management.
Before a claim leaves your lab, it passes through our predictive engine. We do not just check for typos. We validate every line item against a live library of active billing edits, including NCCI bundling pairs, LCD medical necessity policies, payer‑specific frequency limits, and 2026 FDA oversight rules for high‑risk Laboratory Developed Tests (LDTs). Non‑compliant LDTs are flagged and corrected before submission.

Real-Time Eligibility and Auth

For high-cost tests, we automate the Prior Authorization process. We verify eligibility and benefits at the moment of accession, ensuring the patient actually has coverage for the specific panel ordered.

We validate every line item against a live library of active billing edits, including NCCI bundling pairs, LCD medical necessity policies, and payer-specific frequency limits.

Tired of Fighting AI Denials With Manual Appeals?

We use predictive risk scoring to stop denials before they happen. Let us show you which claims in your queue are already at risk.

Our Guaranteed Results For Your Laboratory Success

KPIs that reflect our commitment to your revenue success.

Reduction in Billing Errors
99 %
Reduction in AR
40 %
First Pass Clean Claims Rate
95 %+
Revenue Increase
Up to 20 %
Denial Rate
4 %
Turnaround Time
7- 14 Days

Surgical Appeal Strategies for Top Lab Denials

When a denial does happen, we don’t send a form letter. We sent a forensic argument. Generic appeals get generic rejections. Our lab denial resolution team breaks down rejections by code and counter-attacks using RPA-enabled appeal submission.

We combine root cause, payer language, and our technical fix into one Technical Resolution Matrix

Metric The Payer's Argument Our Solution
CO-50: Medical Necessity "The diagnosis does not support this panel." We pull the ordering provider's history and prior successes to prove longitudinal complexity capture. We attach the specific LCD article proving coverage.
CO-97: Bundling (CCI Edits) "This test is included in another code." We analyze NCCI Edits to identify if a 59 or X{EPSU} modifier is genuinely warranted. If the test is distinct, we fight for separate reimbursement.
CO-16: Info Missing "Claim lacks information." Usually a missing date of collection or referring to NPI. Our bots scrape the LIS to fill the gap and resubmit in 24 hours.

Silent Denials & Pending Claim Liquidation (2026 Payer Edits)

In 2026, payers are increasingly using Internal Processing Edits that are not formal denials. No CARC code is issued, but the claim sits in “Pending” status indefinitely. This is the hidden “silent denial” that starves your cash flow.

We call this the “Black Hole” of pending claims.
We target this Black Hole using a dedicated Pending Claim Liquidation process. Our RPA bots continuously monitor payer portals for stalled claims and force a payer adjudication within 72 hours of submission. By driving a decision (pay or deny), we convert silent inventory into actionable revenue recovery and follow‑up.

Forensic Appeal Workflows for Hard Denials

We use Robotic Process Automation (RPA) to submit these appeals directly into payer portals. This bypasses the mailroom and puts your appeal in front of a reviewer days faster than manual submission.

RPA-Enabled Submission
When a denial does slip through, generic form letters do not work. We use a molecular lab appeal service workflow that builds a legal and clinical argument for payment.
Clinical History

The specific patient notes proving the test was vital for treatment.

LCD/NCD Citations

We attach the exact Local Coverage Determination article that mandates coverage.

Peer-Reviewed Literature

For genetic tests, we include clinical studies supporting the test's validity to counter "experimental" claims.

Claims Sitting in 'Pending' Status for Weeks With No Explanation?

We force adjudication in 72 hours using automated portal monitoring. Stop waiting for payers to act.

2026 Regulatory Compliance Shield and Audit Protection

The regulatory environment for labs is hostile. We protect your margins from legislative cuts and compliance risks.
SALSA Readiness (Saving Access to Laboratory Services Act)

2026 is a critical year for SALSA. Labs are now required to report private payer data to CMS to prevent massive 15% rate cuts. Data reporting determines your future reimbursement. Our denial management platform automatically aggregates and normalizes the private payer payment data required for SALSA reporting, ensuring your lab contributes accurate market rates to CMS. We don't just recover revenue; we protect your future rates by ensuring your reported data to CMS is accurate and audit‑proof under the 2026 SALSA mandates. This protects the CLFS (Clinical Laboratory Fee Schedule) from arbitrary rate cuts.

SALSA Readiness (Saving Access to Laboratory Services Act)

For out‑of‑network or cash‑pay patients, transparency is law. We automate the generation of Good Faith Estimates (GFE) and the Advanced Explanation of Benefits (AEOB) required under the 2026 NSA Final Rule. This prevents patient disputes, reduces “surprise bill” litigation risk, and keeps you compliant with federal price transparency rules.

Post-Payment Audit Defense

Payers use RAC (Recovery Audit Contractors) to claw back money years after payment. We analyze your historical data to find patterns that trigger these audits. We “audit‑proof” your documentation now so you are safe later.

Specialty-Specific Denial Logic

A Toxicology lab cannot be billed like a Pathology lab. We customize our rules for your specific science.
Molecular and Genetic Labs

We focus on MolDX, Z‑Codes, and establishing medical necessity for hereditary cancer and PGx panels. We explicitly manage combinatorial PGx logic, ensuring multi‑gene pharmacogenomic panels are billed as a single unit where required, maintaining unit‑level compliance with payer rules. We know how to fight the "genetic counseling not documented" denial.

Toxicology and Pain Labs

We strictly monitor qualitative vs. quantitative frequency limits. We ensure your billing frequency matches the patient's risk profile to avoid "frequency exceeded" denials.

Clinical and Anatomic Pathology

We manage the split between the Technical Component (TC) and the Professional Component (26). We ensure 88305 codes are utilized correctly and supported by the pathology report.

Worried About SALSA Reporting or RAC Audits?

We aggregate your private payer data for CMS reporting and audit-proof your documentation before RAC contractors come knocking.

Security and Technology Standards

2026 Margin Protection: Turning Denial Management into a Profit Center

The technology exists to stop 99% of lab billing errors. If your current billing partner is not using it, they are not managing your revenue. They are managing your decline.

Frequently Asked Questions

Do we need to replace our LIS to work with you?
No. We build a bridge to your existing LIS (Laboratory Information System). We pull demographic and coding data, scrub it through our engine, and push it to the payer. Your lab workflow does not change.
Yes. For low-balance claims where manual work isn’t profitable, we use automated bots. These bots identify the error (like a missing NPI), correct it, and resubmit in bulk. This recovers revenue that most labs write off as “not worth the effort.”
This is usually a Z-Code issue. We verify your test registration with MolDX. If the test is registered but still denied, we appeal using the specific LCD article and clinical utility studies that prove the test is medically necessary, not experimental.
We do not just bill what is sent. If the code is generic (like “Fatigue”), our NLP system scans the doctor’s notes for more specific conditions that justify the panel. We help you query the provider to update the order before billing.